Hexosaminidase A deficiency in adults.

Deficiency of hexosaminidase A (Hex A) in adults was found in 15 individuals from nine unrelated Ashkenazi families; 14 individuals had neurological symptoms, one was clinically intact. Clinical, biochemical and genetic findings are reported and compared to previously reported cases. The clinical picture varied between and within families and included spinocerebellar, various motor neuron and cerebellar syndromes. Psychosis appeared in 30% of cases. Involvement of three generations was recorded in one family. The phenotype appears too variable to serve as a basis for genetic classification. The level of Hex A activity in serum, leukocytes, and fibroblasts of all 14 patients was in the range of Tay-Sachs disease (TSD) homozygotes when measured by the routine heat-inactivation method. More sensitive and direct methods detected some residual activity. Cultured skin fibroblasts of patients synthesize the alpha and beta chain precursors of Hex A of the same molecular weight as that synthesized by normal fibroblasts. However, the amount of the alpha chain precursor is greatly reduced. Mature chains were not detected. The one healthy adult we studied displayed a nonuniform distribution of Hex A; while it lacked activity in the serum it had intermediate activity in fibroblasts and leukocytes.

[1]  O'Brien Js.  Suggestions for a nomenclature for the GM2 gangliosidoses making certain (possibly unwarrantable) assumptions. , 1978 .

[2]  J. O'brien,et al.  Absence of -N-acetyl-D-hexosaminidase A activity in a healthy woman. , 1973, American journal of human genetics.

[3]  R. Navon,et al.  Adult‐onset GM2 gangliosidosis diagnosed in a fetus , 1986, Prenatal diagnosis.

[4]  R. Navon,et al.  Clinical and genetic variations in the syndrome of adult GM2 gangliodosis resulting from hexosaminidase a deficiency , 1984, Annals of neurology.

[5]  R. Proia,et al.  cDNA clone for the alpha-chain of human beta-hexosaminidase: deficiency of alpha-chain mRNA in Ashkenazi Tay-Sachs fibroblasts. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Mitsumoto,et al.  Motor neuron disease and adult hexosaminidase a deficiency in two families: Evidence for multisystem degeneration , 1985, Annals of neurology.

[7]  R. Lüllmann-Rauch.  Drug-induced lysosomal storage disorders. , 1979, Frontiers of biology.

[8]  R. Navon,et al.  Hexosaminidase a deficient adults: Presence of α chain precursor in cultured skin fibroblasts , 1984 .

[9]  J. Cook,et al.  Lead content of cerebrospinal fluid and other tissue in amyotrophic lateral sclerosis (ALS) , 1979 .

[10]  K. Sandhoff,et al.  Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. , 1983, American journal of human genetics.

[11]  R. Navon,et al.  Frequency of hexosaminidase A variant alleles among Ashkenazi Jews and prenatal diagnosis of GM2 gangliosidosis. , 1985, American journal of human genetics.

[12]  M. Adachi,et al.  Ultrastructural studies of eight cases of fetal Tay-Sachs disease. , 1974, Laboratory investigation; a journal of technical methods and pathology.

[13]  D. Mahuran,et al.  The subunit and polypeptide structure of hexosaminidases from human placenta. , 1980, Canadian journal of biochemistry.

[14]  J. O'brien,et al.  Segregation within a family of two mutant alleles for hexosaminidase A , 1976, Clinical genetics.

[15]  J. Stirling,et al.  N-Acetyl-β-glucosaminidases in human spleen , 1968 .

[16]  R. Navon,et al.  Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. , 1973, American journal of human genetics.

[17]  R. Desnick,et al.  Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia , 1981, Neurology.

[18]  A. Hasilik,et al.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. , 1980, The Journal of biological chemistry.

[19]  I. Rapin,et al.  Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship. , 1976, Archives of neurology.

[20]  L. Uotila.  Polymorphism of red cell S-formylglutathione hydrolase in a Finnish population. , 1984, Human heredity.

[21]  E. Brett,et al.  Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients. , 1973, Archives of disease in childhood.

[22]  B. Geiger,et al.  Low levels of beta hexosaminidase A in healthy individuals with apparent deficiency of this enzyme. , 1976, American journal of human genetics.

[23]  W. Johnson.  The clinical spectrum of hexosaminidase deficiency diseases , 1981, Neurology.

[24]  R. Proia,et al.  Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Rowland,et al.  Juvenile spinal muscular atrophy: A new hexosaminidase deficiency phenotype , 1981, Annals of neurology.

[26]  J. O'brien,et al.  Juvenile GM2 gangliosidosis: partial deficiency of hexosaminidase A. , 1970, The Journal of pediatrics.

[27]  S. Raghavan,et al.  GM2-gangliosidosis Hexosaminidase mutations not of the Tay-Sachs type procedure unusual clinical variants , 1983, Trends in Neurosciences.

[28]  D. Greenberg,et al.  Estimation of the frequency of hexosaminidase a variant alleles in the American Jewish population. , 1982, American journal of human genetics.

[29]  R. Navon,et al.  Adult GM2 gangliosidosis in association with Tay‐Sachs disease , 1981, Neurology.

[30]  H. Kazazian,et al.  Nonuniform Deficiency of Hexosaminidase A in Tissues and Fluids of Two Unrelated Individuals , 1982, Pediatric Research.

[31]  Kunihiko Suzuki,et al.  Partial deficiency of hexosaminidase component A in juvenile GM2‐gangliosidosis , 1970, Neurology.

[32]  R. Proia,et al.  Faulty association of alpha- and beta-subunits in some forms of beta-hexosaminidase A deficiency. , 1984, The Journal of biological chemistry.